**Abstract**

**Background:** We investigated the changes of oxy-Hb concentration over the remission process in depressive patients using multi-channel NIRS detecting changes in local blood flow in the cerebral cortex in the frontal and temporal regions while pleasant/ unpleasant image recall tasks.

**Methods:** Change of oxy-Hb during verbal shiritori tasks (standard and category version) was recorded in the bilateral 22 recoding parts using NIRS. For Baum-test, the tree crown removal method was used.

The patient was a 28-year-old male who had never been examined at a psychiatry department or received drug therapy. He had no problem at the time of birth or in the school period. He had worries of work, and depressive state, suicidal ideation, and inability to sleep continued for about one month. The patient was referred to our department by his primary care physician in January 20XX. Depressive state and suicidal ideation continued. He was diagnosed with major depression based on ICD-10 (HAM-D: 25, SDS: 52).

**Course and Results:** Outpatient drug therapy (escitalopram: 10 mg) was initiated after he promised not to commit suicide and his family promised to watch him. The escitalopram dose was increased to 20 mg, suicide ideation disappeared after about one month of treatment, loss of motivation was improved (HAM-D: 15, SDS: 45), and the patient started rehabilitation at our department. His willingness to work became strong and the condition improved to starting a part-time job after 3 months (HAM-D: 8, SDS: 40). Baum grew with remission, and fruits and houses appeared.

After initiation of a part-time job for rehabilitation into society, oxy-Hb increased in the frontal area while recalling pleasant/ unpleasant images.

**Discussion:** Escitalopram is effective for depressive patients. Multi-facet observation of the treatment course based on oxygenated hemoglobin and Baum and its feedback to patients and their families are useful.
